Shanghai, China

Zuoquan Xie

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignees: Chinese Academy of Sciences, China Pharmaceutical University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zuoquan Xie. Retrieved from https://idiyas.com/inventor/zuoquan-xie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.3

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zuoquan Xie: Innovator in Pharmaceutical Chemistry

Introduction

Zuoquan Xie is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of new compounds.

Latest Patents

Zuoquan Xie holds a patent for a fluorine-containing substituted benzothiophene compound, along with its pharmaceutical composition and applications. This compound is described in detail, showcasing its structure and the definitions of each group and substituent. The patent also outlines a preparation method for the compound and its application in anti-tumor treatments.

Career Highlights

Zuoquan Xie is affiliated with the Chinese Academy of Sciences, where he conducts his research. His work has led to advancements in the development of pharmaceutical compounds that have the potential to impact cancer treatment.

Collaborations

Zuoquan Xie has collaborated with notable colleagues, including Ao Zhang and Meiyu Geng, contributing to a dynamic research environment that fosters innovation.

Conclusion

Zuoquan Xie's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in the advancement of medical science. His work continues to pave the way for new therapeutic options in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…